U. Wintergerst et al., Use of saliva specimens for monitoring indinavir therapy in human immunodeficiency virus-infected patients, ANTIM AG CH, 44(9), 2000, pp. 2572-2574
Indinavir concentrations were determined in plasma and saliva over a random
period of 4 h. On average, levels in saliva were 70% +/- 38% of the corres
ponding levels in plasma. These findings suggest that saliva might serve as
an appropriate specimen for monitoring of plasma indinavir levels in patie
nts treated with indinavir.